21Shares Polkadot ETF 8-K

What Happened
21Shares Polkadot ETF (via sponsor 21Shares US LLC) filed an 8-K on July 7, 2026 reporting that it gave notice to CF Benchmarks Ltd. on June 30, 2026 to terminate the Pricing Benchmark Licensing Agreement effective August 31, 2026. The agreement covers use of the CME CF Polkadot — Dollar Reference Rate — New York Variant, which is used to value the Trust’s shares and to calculate the Trust’s net asset value (NAV). The sponsor plans to enter into a new licensing agreement with FTSE International Limited on or about August 24, 2026 to provide FTSE index data for the Trust.

Key Details

• Termination notice sent: June 30, 2026; termination effective: August 31, 2026.
• Pricing Benchmark: CME CF Polkadot — Dollar Reference Rate — New York Variant (provided by CF Benchmarks).
• New provider: FTSE International Limited; sponsor expects to enter agreement on or about August 24, 2026.
• License terms described: non-exclusive, non-transferable, non-sub-licensable, worldwide (agreement has one-year initial term with automatic one-year renewals). CF Benchmarks and FTSE are unaffiliated with the sponsor.

Why It Matters
The benchmark used to value the ETF’s shares and calculate NAV is changing providers. The filing indicates the sponsor is transitioning from CF Benchmarks to FTSE and has timed the new license to begin before the CF Benchmarks license terminates, which should maintain pricing continuity. The 8-K does not state any change to the fund’s investment strategy, fees, or operations beyond the benchmark-provider change. Investors should note the dates and watch for any future notices or prospectus updates that describe the new FTSE benchmark methodology or any operational impacts.